Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elio Scarpini

Showing results (11-20 of 329) with videos related to

Pageof 33
Sort By:
Expert Opinion on Emerging Drugs|January 29, 2016
Emerging amyloid disease-modifying drugs for Alzheimer's diseaseDaniela Galimberti, Elio Scarpini
CNS & Neurological Disorders Drug Targets|January 13, 2011
Alzheimer's disease: from pathogenesis to disease-modifying approachesDaniela Galimberti, Elio Scarpini
Journal of Neurology|April 19, 2013
Progress in Alzheimer's disease research in the last yearDaniela Galimberti, Elio Scarpini
Expert Opinion on Investigational Drugs|July 27, 2016
Old and new acetylcholinesterase inhibitors for Alzheimer's diseaseDaniela Galimberti, Elio Scarpini
Current Topics in Behavioral Neurosciences|January 21, 2012
Behavioral genetics of neurodegenerative disordersDaniela Galimberti, Elio Scarpini
Journal of Neurology|June 28, 2011
Progress in Alzheimer's diseaseDaniela Galimberti, Elio Scarpini
Acta Medica Portuguesa|September 11, 2013
Dementia: not only Alzheimer's disease, an eye on frontotemporal dementiaDaniela Galimberti, Elio Scarpini
The Lancet. Neurology|August 28, 2003
Treatment of Alzheimer's disease: current status and new perspectivesElio Scarpini, Philip Scheltens, Howard Feldman
Drug Design, Development and Therapy|December 20, 2013
Disease-modifying drugs in Alzheimer's diseaseLaura Ghezzi, Elio Scarpini, Daniela Galimberti
Expert Opinion on Therapeutic Targets|June 12, 2018
Progranulin as a therapeutic target for dementiaDaniela Galimberti, Chiara Fenoglio, Elio Scarpini
Pageof 33

Showing results (11-20 of 329) with videos related to

Sort By:
Pageof 33
Expert Opinion on Emerging Drugs|January 29, 2016
Emerging amyloid disease-modifying drugs for Alzheimer's diseaseDaniela Galimberti, Elio Scarpini
CNS & Neurological Disorders Drug Targets|January 13, 2011
Alzheimer's disease: from pathogenesis to disease-modifying approachesDaniela Galimberti, Elio Scarpini
Journal of Neurology|April 19, 2013
Progress in Alzheimer's disease research in the last yearDaniela Galimberti, Elio Scarpini
Expert Opinion on Investigational Drugs|July 27, 2016
Old and new acetylcholinesterase inhibitors for Alzheimer's diseaseDaniela Galimberti, Elio Scarpini
Current Topics in Behavioral Neurosciences|January 21, 2012
Behavioral genetics of neurodegenerative disordersDaniela Galimberti, Elio Scarpini
Journal of Neurology|June 28, 2011
Progress in Alzheimer's diseaseDaniela Galimberti, Elio Scarpini
Acta Medica Portuguesa|September 11, 2013
Dementia: not only Alzheimer's disease, an eye on frontotemporal dementiaDaniela Galimberti, Elio Scarpini
The Lancet. Neurology|August 28, 2003
Treatment of Alzheimer's disease: current status and new perspectivesElio Scarpini, Philip Scheltens, Howard Feldman
Drug Design, Development and Therapy|December 20, 2013
Disease-modifying drugs in Alzheimer's diseaseLaura Ghezzi, Elio Scarpini, Daniela Galimberti
Expert Opinion on Therapeutic Targets|June 12, 2018
Progranulin as a therapeutic target for dementiaDaniela Galimberti, Chiara Fenoglio, Elio Scarpini
Pageof 33